Elena Ridloff - 16 Jun 2021 Form 4/A - Amendment Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Director
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
Issuer symbol
KYMR
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
15 Apr 2022, 16:15:48 UTC
Date Of Original Report
17 Jun 2021
Previous filing
15 Apr 2022
Next filing
23 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYMR Stock Option (Right to Buy) Award $0 +10,459 $0.000000 10,459 16 Jun 2021 Common Stock 10,459 $49.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders.

Remarks:

This Amended Form 4 restates the original Form 4 in its entirety.